{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:24:51Z","timestamp":1793795091468,"version":"4.6.1"},"reference-count":0,"publisher":"China Medical University","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BioMedicine"],"abstract":"<jats:p>Objectives: This study tried to examine the ability of the estimated plasma gene-expression levels (PGEL) of microRNA (miR)-146a and miR-21b to distinguish patients with early rheumatoid arthritis (RA) out of arthritis patients who did not fulfill the diagnostic spectrum of either RA or osteoarthritis (OA); the diagnostic Gray-Zone (GZ).\nPatients &amp; Methods: Enrolled patients underwent full diagnostic workup and were categorized as highseropositive and fulfilled the diagnostic spectrum for RA (RA-group), seronegative and fulfilling the diagnostic spectrum of OA (OA-group) and low-seropositive or seronegative patients who did not fulfill diagnostic criteria of RA or OA (GZ-group). Blood samples were obtained for quantification of PGEL of miR-146a and miR-21-b using the quantitative Reverse-transcriptase polymerase chain reaction and results were related to patients' seropositivity and clinical data.\nResults: The mean fold change of PGEL of miR-146a and miR-21b was significantly higher in patients than in control samples, in samples of high-seropositive patients than in other samples, and in samples of low-seropositive than in seronegative patients. Both markers showed a positive significant correlation with Disease Activity Score-28 for RA-activity and seropositivity. Using the ROC curve analysis, the PGEL of both microRNAs could identify high-seropositive among the studied arthritis patients, but Regression Analysis defined high PGEL of miR-146a as the most significant predictor to identify RApatients and predict their disease activity. Statistical analyses defined miR-146a as the significant parameter that could differentiate between early RA and OA patients among GZ patients.\nConclusion: Early arthritis that does not fulfill the diagnostic spectrum of a certain type of arthritis is not uncommon and challenges therapeutic decision-making. The estimated PGEL of MicroRNA-146a might enlighten this gray diagnostic zone and allow differentiation between patients with early RA and early OA, and help to stratify RA patients according to disease activity and severity.<\/jats:p>","DOI":"10.37796\/2211-8039.1637","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T17:34:24Z","timestamp":1741023264000},"source":"Crossref","is-referenced-by-count":5,"title":["Plasma Levels of miR-21b and miR-146a Can Discriminate Rheumatoid Arthritis Diagnosis and Severity."],"prefix":"10.37796","volume":"15","author":[{"given":"Rizk S.","family":"Sarhan","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Benha University, Benha, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr M","family":"El-Hammady","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Benha University, Benha, Egypt."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin M","family":"Marei","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry & Molecular Biology, Faculty of Medicine, Benha University, Benha, Egypt."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sania K","family":"Elwia","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Benha University, Benha, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa M","family":"Ismail","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine, Rheumatology & Rehabilitation, Faculty of Medicine, Tanta University, Tanta, Egypt."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emtethal AS","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine, Rheumatology & Rehabilitation, Faculty of Medicine, Benha University, Benha, Egypt."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"12796","published-online":{"date-parts":[[2025,2,27]]},"container-title":["BioMedicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T11:24:45Z","timestamp":1793791485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomedicinej.com\/biomedicine\/vol15\/iss1\/5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,27]]}},"URL":"https:\/\/doi.org\/10.37796\/2211-8039.1637","relation":{},"ISSN":["2211-8039"],"issn-type":[{"value":"2211-8039","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]}}}